Cited by 289Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.

Marijuana and cannabinoid regulation of brain reward circuits

Open access

Lupica, Carl R, Riegel, Arthur C, Hoffman, Alexander F·2004·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0705931PMC PMC1575338

Open this paper in CoChat — free account Open PDF

Abstract

The reward circuitry of the brain consists of neurons that synaptically connect a wide variety of nuclei. Of these brain regions, the ventral tegmental area (VTA) and the nucleus accumbens (NAc) play central roles in the processing of rewarding environmental stimuli and in drug addiction. The psychoactive properties of marijuana are mediated by the active constituent, Delta(9)-THC, interacting primarily with CB1 cannabinoid receptors in a large number of brain areas. However, it is the activation of these receptors located within the central brain reward circuits that is thought to play an important role in sustaining the self-administration of marijuana in humans, and in mediating the anxiolytic and pleasurable effects of the drug. Here we describe the cellular circuitry of the VTA and the NAc, define the sites within these areas at which cannabinoids alter synaptic processes, and discuss the relevance of these actions to the regulation of reinforcement and reward. In addition, we compare the effects of Delta(9)-THC with those of other commonly abused drugs on these reward circuits, and we discuss the roles that endogenous cannabinoids may play within these brain pathways, and their possible involvement in regulating ongoing brain function, independently of marijuana consumption. We conclude that, whereas Delta(9)-THC alters the activity of these central reward pathways in a manner that is consistent with other abused drugs, the cellular mechanism through which this occurs is likely different, relying upon the combined regulation of several afferent pathways to the VTA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705931

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616

Flagged first, then by citations

Show all 85 references

1 of the 85 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

10.1111/j.1460-9568.1998.00292.x · DOI
RIEGEL A.C., 2003, Cannabinoid CB1 receptors inhibit GABAB‐mediated synaptic currents in midbrain dopamine neurons, Soc. Neurosci. Abstr., 33

Sorted by citations

The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 829
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732
Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Lopez‐Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 733
The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 518
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Bossong, M., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R., Windhorst, A., van Gerven, J. V., Ramsey, N., Lammertsma, A., & Kahn, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 262
Endocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387
Male Sexual Behavior
Hull, E. M., & Rodrı́guez–Manzo, G. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00001-2 · Cited by 374
One Is Not Enough: Understanding and Modeling Polysubstance Use
Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
Bostwick, J. M. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.003 · Cited by 261
Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction
Lupica, C. R., & Riegel, A. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.016 · Cited by 268
Self-citation
Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users
Gilman, J. M., Kuster, J. K., Lee, S., Lee, M. J., Kim, B. W., Makris, N., van der Kouwe, A., Blood, A. J., & Breiter, H. C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4745-13.2014 · Cited by 250
“Second, animal studies have demonstrated that exogenous and endogenous cannabinoids can significantly alter synaptic transmission in the nucleus accumbens (Lupica et al., 2004) and in the amygdala (Azad et al., 2004).”
Background
The endocannabinoid system in brain reward processes
Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 251
Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233
WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease
Price, D. A., Martinez, A. A., Seillier, A., Koek, W., Acosta, Y. P. V., Fernández, E., Strong, R., Lutz, B., Marsicano, G., Roberts, J. L., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06764.x · Cited by 231
The endocannabinoid system: emotion, learning and addiction
Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 233
Endocannabinoids in the regulation of appetite and body weight
Kirkham, T. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00004 · Cited by 224
Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration
Sòria, G., Mendizábal, V. E., Touriño, C., Robledo, P., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300707 · Cited by 214
A new control center for dopaminergic systems: pulling the VTA by the tail
Bourdy, R., & Barrot, M. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.007 · Cited by 222
The Role of cannabinoids in neuroanatomic alterations in cannabis users.
Lorenzetti, V., Solowij, N., & Yücel, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.013 · Cited by 208
“Hannerz and Hindmarsh, 1983 (66) 12 (8) 12 (8) 26 26 10 — — — — — — — — — —”
BackgroundInfluential
A review of co‐morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co‐use
Rabin, R. A., & George, T. P. (2015) · American Journal on Addictions · doi:10.1111/ajad.12186 · Cited by 210
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Jordan, C. J., & Xi, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 207
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
Hill, M. N., & Gorzalka, B. B. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00006 · Cited by 196
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area
Mátyás, F., Urbán, G. M., Watanabe, M., Mackie, K., Zimmer, A., Freund, T. F., & Katona, I. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.028 · Cited by 187
Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens
Wightman, R. M., Heien, M. L., Wassum, K. M., Sombers, L. A., Aragona, B. J., Khan, A. S., Ariansen, J. L., Cheer, J. F., Phillips, P. E. M., & Carelli, R. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05772.x · Cited by 179
Chronic effects of cannabis use on the human reward system: An fMRI study
van Hell, H. H., Vink, M., Ossewaarde, L., Jager, G., Kahn, R. S., & Ramsey, N. F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.010 · Cited by 181
Two brain sites for cannabinoid reward
Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R., & Wise, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3554-05.2006 · Cited by 174
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
Öz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 164
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Fernández‐Ruíz, J., Hernández, M., & Ramos, J. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00144.x · Cited by 163
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c‐Fos expression in the hypothalamus
Gómez, E. S., Matias, I., Rueda‐Orozco, P. E., Cisneros, M., Petrosino, S., Navarro, L., Marzo, V. D., & Prospero-Garcia, O. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707313 · Cited by 158
Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse
Ji, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 156
A role for cannabinoid CB1 receptors in mood and anxiety disorders
Witkin, J. M., Tzavara, E. T., & Nomikos, G. G. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00005 · Cited by 160
The endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
Microbiota‐gut‐brain axis as a regulator of reward processes
García‐Cabrerizo, R., Carbia, C., O’Riordan, K. J., Schellekens, H., & Cryan, J. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15284 · Cited by 150
Deficits in striatal dopamine release in cannabis dependence
van de Giessen, E., Weinstein, J. J., Cassidy, C., Haney, M., Dong, Z., Ghazzaoui, R., Ojeil, N., Kegeles, L. S., Xu, X., Vadhan, N. P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.21 · Cited by 136
Self-administration of cannabinoids by experimental animals and human marijuana smokers
Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137
Cannabis and the developing brain: Insights from behavior
Trezza, V., Cuomo, V., & Vanderschuren, L. J. M. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.058 · Cited by 131
The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
López‐Moreno, J. A., González‐Cuevas, G., Moreno, G., & Navarro, M. A. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00105.x · Cited by 132
Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in rats
Fattore, L., Spano, M. S., Cossu, G., Deiana, S., & Fratta, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02607.x · Cited by 128
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 132
The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence
Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 129
Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors
Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119
Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119
Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats
Xi, Z., Spiller, K. J., Pak, A. C., Gilbert, J. G., Dillon, C., Li, X., Peng, X., & Gardner, E. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301552 · Cited by 115
Cannabinoid self-administration increases dopamine release in the nucleus accumbens
Fadda, P., Scherma, M., Spano, M. S., Salis, P., Melis, V., Fattore, L., & Fratta, W. (2006) · Neuroreport · doi:10.1097/01.wnr.0000236853.40221.8e · Cited by 114
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 122
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers
Haney, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301243 · Cited by 113
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens
Mateo, Y., Johnson, K. A., Covey, D. P., Atwood, B. K., Wang, H., Zhang, S., Gildish, I., Cachope, R., Bellocchio, L., Guzmán, M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.012 · Cited by 111
Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment
Morris, C. V., DiNieri, J. A., Szutorisz, H., & Hurd, Y. L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07884.x · Cited by 113
Cannabis in Sport
Huestis, M. A., Mazzoni, I. E., & Rabin, O. (2011) · Sports Medicine · doi:10.2165/11591430-000000000-00000 · Cited by 110
A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions
Orío, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 111
Blocking cannabinoid CB1receptors for the treatment of nicotine dependence: insights from pre‐clinical and clinical studies
Foll, B. L., Forget, B., Aubin, H., & Goldberg, S. R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00113.x · Cited by 108
Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox
Wise, R. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.001 · Cited by 100
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area
Wang, H., Treadway, T., Covey, D. P., Cheer, J. F., & Lupica, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.041 · Cited by 95
Self-citation
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine
Viganò, D., Valenti, M., Cascio, M. G., Marzo, V. D., Parolaro, D., & Rubino, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03645.x · Cited by 97
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat
Spano, M. S., Fattore, L., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705932 · Cited by 95
Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivoΔ9‐THC exposure‐impaired hippocampal synaptic plasticity
Fan, N., Yang, H., Zhang, J., & Chen, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06489.x · Cited by 92
The role of CB1 receptors in psychostimulant addiction
Wiskerke, J., Pattij, T., Schoffelmeer, A. N. M., & Vries, T. J. D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00109.x · Cited by 91
Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking
Gamaleddin, I., Wertheim, C. E., Zhu, A. Z. X., Coen, K. M., Vemuri, K. V., Makryannis, A., Goldberg, S. R., & Foll, B. L. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00314.x · Cited by 94
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia
Tao, R., Li, C., Jaffe, A. E., Shin, J. H., Deep‐Soboslay, A., Yamin, R., Weinberger, D. R., Hyde, T. M., & Kleinman, J. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0832-8 · Cited by 90
Drug-induced Alterations in the Extracellular Signal-regulated Kinase (ERK) Signalling Pathway: Implications for Reinforcement and Reinstatement
Zhai, H., Li, Y., Wang, X., & Lü, L. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9240-3 · Cited by 91
Bidirectional regulation of mu‐opioid and CB1‐cannabinoid receptor in rats self‐administering heroin or WIN 55,212‐2
Fattore, L., Viganò, D., Fadda, P., Rubino, T., Fratta, W., & Parolaro, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05470.x · Cited by 89
PRECLINICAL STUDY: FULL ARTICLE: Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR‐α nuclear receptors
Luchicchi, A., Lecca, S., Carta, S., Pillolla, G., Muntoni, A. L., Yaşar, S., Goldberg, S. R., & Pistis, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00222.x · Cited by 88
Chronic treatment with Δ‐9‐tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats
Kolb, B. E., Gorny, G., Limebeer, C. L., & Parker, L. A. (2006) · Synapse · doi:10.1002/syn.20313 · Cited by 84
Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
Katzman, M., & Sternat, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111818 · Cited by 83
SR141716A reduces the reinforcing properties of heroin but not heroin‐induced increases in nucleus accumbens dopamine in rats
Caillé, S., & Parsons, L. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.02961.x · Cited by 83
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
Colizzi, M., Weltens, N., McGuire, P. K., Lythgoe, D. J., Williams, S., Oudenhove, L. V., & Bhattacharyya, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0374-8 · Cited by 74
Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice
Li, X., Hoffman, A. F., Peng, X., Lupica, C. R., Gardner, E. L., & Xi, Z. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1432-0 · Cited by 74
Self-citation
Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model
Oltrabella, F., Melgoza, A., Nguyen, B., & Guo, S. (2017) · Development Growth & Differentiation · doi:10.1111/dgd.12351 · Cited by 72
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Spiller, K. J., Bi, G., He, Y., Galaj, E., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14625 · Cited by 67
Basic neuroanatomy and neuropharmacology of cannabinoids
Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 71
Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area
Linsenbardt, D. N., & Boehm, S. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.007 · Cited by 66
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Mason, N. L., Theunissen, E. L., Hutten, N. R. P. W., Tse, D. H. Y., Toennes, S. W., Stiers, P. L. J., & Ramaekers, J. G. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.003 · Cited by 64
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice
Han, X., He, Y., Bi, G., Zhang, H., Song, R., Liu, Q., Egan, J. M., Gardner, E. L., Li, J., & Xi, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-12399-z · Cited by 66
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Galaj, E., & Xi, Z. (2019) · CNS Drugs · doi:10.1007/s40263-019-00664-w · Cited by 69
Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats
Braida, D., & Sala, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704825 · Cited by 63
A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and AddictionPreprint
Peters, K. Z., Oleson, E. B., & Cheer, J. F. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039305 · Cited by 64
Age-varying time trends in cannabis- and alcohol-related risk perceptions 2002–2019
Waddell, J. T. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107091 · Cited by 61
Construction of a Polyheterocyclic Benzopyran Library with Diverse Core Skeletons through Diversity-Oriented Synthesis Pathway
Oh, S., Jang, H. J., Ko, S. K., Ko, Y., & Park, S. B. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100044w · Cited by 60
Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date
Sami, M. B., Rabiner, E. A., & Bhattacharyya, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.011 · Cited by 62
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist
Justinová, Z., Ferré, S., Redhi, G. H., Mascia, P., Stroik, J., Quarta, D., Yaşar, S., Müller, C. E., Franco, R., & Goldberg, S. R. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00258.x · Cited by 58
Central nervous system effects of haloperidol on THC in healthy male volunteers
Liem-Moolenaar, M., Beek, E. T. T., de Kam, M. L., Franson, K. L., Kahn, R. S., Hijman, R., Touw, D. J., & van Gerven, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358200 · Cited by 59
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
Bossong, M. G., Jansma, J. M., Bhattacharyya, S., & Ramsey, N. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 62
Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons
Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 62
Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies
Khoury, M. E., Gorgievski, V., Moutsimilli, L., Bruno Giros, A., & Tzavara, E. T. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.005 · Cited by 58
Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
Mason, N. L., Theunissen, E. L., Hutten, N. R. P. W., Tse, D. H. Y., Toennes, S. W., Jansen, J. F. A., Stiers, P. L. J., & Ramaekers, J. G. (2019) · Addiction Biology · doi:10.1111/adb.12870 · Cited by 62
Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous SystemPreprint
Hoffman, A. F., & Lupica, C. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012237 · Cited by 60
Self-citation
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-Like Behavior
Mancino, S., Burokas, A., Cuesta, J., Gutiérrez‐Martos, M., Martín‐García, E., Pucci, M., Falconi, A., D’Addario, C., Maccarrone, M., & Maldonado, R. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.129 · Cited by 57
Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats
Wegener, N., Kuhnert, S., Thüns, A., Roese, R., & Koch, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1148-1 · Cited by 57
Role of γ‐Aminobutyric Acid (GABA) and Metabotropic Glutamate Receptors in Nicotine Reinforcement: Potential Pharmacotherapies for Smoking Cessation
Markou, A., Paterson, N. E., & Semenova, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.061 · Cited by 56
Cannabinoids as hippocampal network administrators
Lupica, C. R., Hu, Y., Devinsky, O., & Hoffman, A. F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.003 · Cited by 55
Self-citation
Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
Ginovart, N., Tournier, B. B., Sallanon, M. M., Steimer, T. J., Ibanez, V., & Millet, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.91 · Cited by 56
Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas
Butovsky, E., Juknat, A., Elbaz, J., Shabat-Simon, M., Eilam, R., Zangen, A., Altstein, M., & Vogel, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.01.008 · Cited by 52
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization
Thiemann, G., VANDERSTELT, M., Petrosino, S., Molleman, A., Marzo, V. D., & Hasenöhrl, R. U. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.022 · Cited by 51
Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell
Luca, M. A. D., Valentini, V., Bimpisidis, Z., Cacciapaglia, F., Caboni, P., & Chiara, G. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00140 · Cited by 51
Animal models of cannabinoid reward
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00775.x · Cited by 48

Authors: Lupica, C. R., Riegel, A. C., & Hoffman, A. F.
Affiliations: National Institutes of Health (US)
Corresponding author: Lupica, Carl R
ORCID: Lupica, Carl R
Riegel, Arthur C
Hoffman, Alexander F
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2004-09
Volume: 143
Issue: 2
Pages: 227-234
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0705931
PMC: PMC1575338
OpenAlex: W1993599253
Cited by: 289
References: 85
Citations by year: 2026: 5 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 17 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 13 · 2017: 14 · 2016: 12 · 2015: 17 · 2014: 13 · 2013: 6 · 2012: 13
FWCI: 1.64
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1630 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabis, delta-9-tetrahydrocannabinol, CB1 receptor, brain reward circuits, ventral tegmental area, nucleus accumbens, drug addiction, self-administration, synaptic regulation, endocannabinoids, reinforcement, psychoactive effects
MeSH terms: Animals, Brain, Cannabinoids, Humans, National Institutes of Health (U.S.), Reward, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Marijuana and cannabinoid regulation of brain reward circuits

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks